Catalys Pacific, LLC

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0002011385
Type: FundHoldings: 2Value: $148.7MLatest: 2025Q1

Catalys Pacific, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 2 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
2
Total Value
148710752
Accession Number
0001104659-25-048317
Form Type
13F-HR
Manager Name
Catalys-Pacific
Data Enrichment
100% identified
2 identified0 unidentified

Holdings

2 positions • $148.7M total value
Manager:
Search and click to pin securities to the top
Mineralys Therapeutics, Inc.
Shares:8.6M
Value:$141.4M
% of Portfolio:95.1% ($141.4M/$148.7M)
Phathom Pharmaceuticals, Inc.
Shares:1.2M
Value:$7.3M
% of Portfolio:4.9% ($7.3M/$148.7M)